TY - JOUR
T1 - Antinociceptive activity of 3-O-β-d-glucopyranosyl-23,24-dihydrocucurbitacin F from Hintonia standleyana (Rubiaceae)
AU - Déciga-Campos, Myrna
AU - Guerrero-Analco, José A.
AU - Quijano, Leovigildo
AU - Mata, Rachel
N1 - Funding Information:
This research was supported by a CONACYT grant (CO1-018) and DGAPA IN212005. Myrna Déciga-Campos is a DGAPA-UNAM postdoctoral fellow. We are indebt to Dr. Vinicio Granados-Soto for valuable discussion and suggestions. We also are grateful to Dr. Jorge E. Torres-López for facilitating the hot plate equipment and to Isabel Rivero, Laura Acevedo, Guadalupe Ángeles and Gabriela Castañeda for technical assistance.
PY - 2006/2
Y1 - 2006/2
N2 - Oral administration of a MeOH-CH2Cl2 (1:1) extract of the stem bark of Hintonia standleyana (HSE) produced a dose-dependent antinociceptive effect when tested in mice using the writhing (150-750 mg/kg) and the hot-plate (150-600 mg/kg) models. From the active extract 3-O-β-d-glucopyranosyl-23,24-dihydrocucurbitacin F (GDHCF), 5-O-[β-d-apiofuranosyl-(1→6)-β-d-glucopyranosyl]-7-methox y-3′,4′-dihydroxy-4-phenylcoumarin (AG4-PC) and desoxycordifolinic acid (DCA) were isolated. GDHCF (10-100 mg/kg, p.o.) significantly reduced acetic acid-induced abdominal contortions and increased the hot-plate latency in comparison to vehicle-treated mice. Metamizol (50-100 mg/kg) and morphine (2.5-5 mg/kg) were used as positive controls, respectively. GDHCF-induced antinociception was partially blocked by naloxone (1 mg/kg, i.p.), l-NAME (150 mg/kg, i.p.) and glibenclamide (10 mg/kg, i.p.) suggesting that its pharmacological effect could be due to the activation of the nitric oxide pathway, followed by the opening of the ATP-sensitive K+ channels, as well as an activation of the opioid receptors.
AB - Oral administration of a MeOH-CH2Cl2 (1:1) extract of the stem bark of Hintonia standleyana (HSE) produced a dose-dependent antinociceptive effect when tested in mice using the writhing (150-750 mg/kg) and the hot-plate (150-600 mg/kg) models. From the active extract 3-O-β-d-glucopyranosyl-23,24-dihydrocucurbitacin F (GDHCF), 5-O-[β-d-apiofuranosyl-(1→6)-β-d-glucopyranosyl]-7-methox y-3′,4′-dihydroxy-4-phenylcoumarin (AG4-PC) and desoxycordifolinic acid (DCA) were isolated. GDHCF (10-100 mg/kg, p.o.) significantly reduced acetic acid-induced abdominal contortions and increased the hot-plate latency in comparison to vehicle-treated mice. Metamizol (50-100 mg/kg) and morphine (2.5-5 mg/kg) were used as positive controls, respectively. GDHCF-induced antinociception was partially blocked by naloxone (1 mg/kg, i.p.), l-NAME (150 mg/kg, i.p.) and glibenclamide (10 mg/kg, i.p.) suggesting that its pharmacological effect could be due to the activation of the nitric oxide pathway, followed by the opening of the ATP-sensitive K+ channels, as well as an activation of the opioid receptors.
KW - 3-O-β-d-glucopyranosyl-23,24-dihydrocucurbitacin F
KW - Antinociception
KW - Cucurbitacins
KW - Desoxycordifolinic acid
KW - Hintonia standleyana
KW - Inflammatory pain
KW - Rubiaceae
UR - http://www.scopus.com/inward/record.url?scp=33646483080&partnerID=8YFLogxK
U2 - 10.1016/j.pbb.2006.02.020
DO - 10.1016/j.pbb.2006.02.020
M3 - Artículo
C2 - 16569425
SN - 0091-3057
VL - 83
SP - 342
EP - 348
JO - Pharmacology Biochemistry and Behavior
JF - Pharmacology Biochemistry and Behavior
IS - 2
ER -